Veritone Updates Date of Third Quarter 2026 Earnings Release and Conference Call

Veritone Updates Date of Third Quarter 2026 Earnings Release and Conference Call

Veritone, Inc. (NASDAQ: VERI) ("Veritone" or the "Company"), a leader in enterprise AI and data solutions, today announced the Company will now release earnings results and hold a conference call on Monday, November 16, 2026, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), to discuss its results for the third quarter 2026, provide an update on the business and conduct a question-and-answer session. The Company has rescheduled the announcement of its earnings results to allow it additional time to provide material updates on the status of its convertible debt discussions and other financing matters.

To participate, please join the conference call or live audio webcast links or use the following dial-in numbers and ask to be connected to the Veritone earnings conference call. To avoid any delays, please join at least fifteen minutes prior to the start of the call.

About Veritone
Veritone (NASDAQ: VERI) builds enterprise AI and data solutions that transform unstructured data into actionable intelligence. Empowering customers in the commercial and public sectors, Veritone helps organizations run more efficiently, accelerate decision-making and increase profitability. Veritone's aiWAREâ„¢ platform orchestrates a robust ecosystem of machine learning models and intelligent applications to transform data, including video, audio, and images, that power smarter models, automated workflows and measurable business outcomes. By blending human expertise with cutting-edge, ethical AI, Veritone enables customers to navigate a rapidly evolving digital landscape, delivering seamless user experiences, sustainable business models, and safeguards for intellectual property owners. To learn more, visit Veritone.com .

Company:
Mike Zemetra
Chief Financial Officer
Veritone, Inc.
investors@veritone.com

Investor Relations:
Cate Goldsmith
Prosek Partners
914-815-7678
pro-veritone@prosek.com

News Provided by Business Wire via QuoteMedia

VERI
The Conversation (0)
Renforth Completes Additional Channel Sampling On Wholly Owned Parbec Gold Deposit In Malartic, Quebec

Renforth Completes Additional Channel Sampling On Wholly Owned Parbec Gold Deposit In Malartic, Quebec

(TheNewswire) TORONTO, Ontario — November 12, 2026 — TheNewswire - Renforth Resources Inc. (CSE: RFR,OTC:RFHRF | OTC: RFHRF | FSE: 9RR) ("Renforth" or the "Company") is pleased to advise shareholders that it has completed additional channel sampling within the stripped area of the open-pit shell... Keep Reading...
Infinity Mining (ASX:IMI)

Extremely High-Grade Antimony with Gold Identified at Surface for Tanjil Dome

Trench sampling intervals return up to 104 g/t AuEq; geology has similarities with the Sunday Creek (ASX: SX2) gold-antimony deposit 100 km away; drill planning underway

Infinity Mining Limited (ASX: IMI) is pleased to report highly promising gold and antimony assays from the initial channel sampling program at Tanjil Dome, where exploration is being undertaken in joint venture with Mining One Consultants. HIGHLIGHTS Assays from trench samples return extremely... Keep Reading...
CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary

CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary

VANCOUVER, BC / ACCESS Newswire / November 10, 2026 / CoTec Holdings Corp. (TSXV:CTH)(OTCQX:CTHCF) ("CoTec" or the "Company") is pleased to announce that it has filed its unaudited interim condensed consolidated financial statements and the accompanying management discussion and analysis... Keep Reading...
Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours

Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), a drug discovery company developing novel therapeutics for autism spectrum disorder ("ASD") and related neurodevelopmental disorders, is... Keep Reading...
Homeland Engages Marketing and Public Relations Company

Homeland Engages Marketing and Public Relations Company

Think Ink Will Focus on Distributing Marketing Materials and AdvertisementsHomeland Nickel Inc. (TSXV: SHL,OTC:SRCGF) (OTCQB: SRCGF) ("Homeland" or the "Company") is pleased to announce it has engaged Think Ink Marketing Data and Email Services Inc. ("Think Ink"), a marketing and public... Keep Reading...

Interactive Chart

Latest Press Releases

Related News